Skip to content

Intra-individual Reproducibility in Nerve Block Duration

Intra-individual Reproducibility in Nerve Block Duration

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03310047
Enrollment
20
Registered
2017-10-16
Start date
2017-10-30
Completion date
2018-03-01
Last updated
2018-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Regional

Brief summary

An interventional randomized controlled crossover trial, to illuminate if durations in nerve block durations are predictable within the same subject.

Detailed description

An interventional randomized controlled crossover trial, with the purpose to elucidate the reproducibility in nerve block duration on 20 healthy volunteers in Denmark. There will be two trial arms: 1: Day one; Right side low dose nerve block and left side high dose nerve block. Repeated after 24 hours. Day three; Left side low dose nerve block and right side high dose nerve block. Repeated after 24 hours 2: Day one; Left side low dose nerve block and right side high dose nerve block Repeated after 24 hours Day three; Right side low dose nerve block and left side high dose nerve block Repeated after 24 hours All volunteers will receive two peripheral nerve blocking catheters adjacent to the common peroneal nerve and will be treated two times on each side with Lidocaine 0.5% 5 mL and 10 mL.

Interventions

DRUGInfusion, Lidocaine, 0.5%, 5 mL

A catheter-based perineural infusion of 5 mL Lidocaine 0.5%

DRUGInfusion, Lidocaine, 0.5%, 10 mL

A catheter-based perineural infusion of 10 mL Lidocaine 0.5%

Sponsors

Innovation Fund Denmark
CollaboratorINDIV
Nordsjaellands Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

The process of intervention-implementation and intervention will not be in the participant's line of sight. Investigators will not be in the room during the intervention. Outcome assessors will not be in the room during the intervention.

Intervention model description

We will use a two-armed crossover design. 1. Day one; Right side low dose nerve block and left side high dose nerve block * Repeated after 24 hours Day three; Left side low dose nerve block and right side high dose nerve block * Repeated after 24 hours 2. Day one; Left side low dose nerve block and right side high dose nerve block * Repeated after 24 hours Day three; Right side low dose nerve block and left side high dose nerve block * Repeated after 24 hours

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age 18 years 2. ASA classification ≤ II

Exclusion criteria

1. Allergy to local anaesthetics 2. Body weight 40 kg 3. Possible peripheral nerve injury or disease, including polyneuropathy and diabetes 4. Enrolment or recent participation in studies that may interfere with this study 5. Habitual use of any kind of analgesic medications 6. Anatomic abnormalities preventing successful US-guided Certa Catheter™ insertion. 7. Pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Duration of insensitivity towards coldUp to 10 hoursTime from nerve block onset time (T1) to nerve block remission (T2)

Secondary

MeasureTime frameDescription
Onset timeUp to 30 minutesTime from infusion (T0) to onset (T1) of the nerve blocking effect
Degree of sensory nerve blockUp to 10 hoursA four step grading-scale of sensory nerve block intensity. 1 = normal, 2 = different, 3 = warm, 4 = no feeling.
Degree of motor nerve blockUp to 10 hoursA three step grading-scale of motor nerve block intensity. 1 = normal, 2 = decreased strength, 3 = no strength.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026